Husband and wife fishing duo Cole & Jay venture into dense lily pads to hunt for a massive monster fish lurking beneath the ...

We are officially entering the golden hour of bass fishing. As the jet skiers and pleasure boaters slowly begin to pack it up ...

Fall bass don’t move because the calendar says they should. Track cooling water, forage, healthy vegetation, hard cover and weather to stay with the fish.

SAN FRANCISCO, Aug 12 (Reuters) - Eli Lilly (LLY.N), opens new tab on Wednesday said it ‌had filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its ...

Two expert anglers are having a successful year and share what's been working to catch heavier fish than other years.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

No other weight-loss medicine has shown efficacy that beats or even matches what retatrutide has demonstrated, not even Zepbound. True, it's always hard to compare across studies. But retatrutide's ...

Add Yahoo as a preferred source to see more of our stories on Google. New photos of the Lily Jean obtained by Boston 25 News show, for the first time, the fishing vessel as it rests on the sea floor ...

The U.S. Navy denied Massachusetts' request to help recover the remains of Lily Jean crew members. Gov. Maura Healey said the state received the letter on Wednesday. The 72-foot vessel sank in frigid ...

Eli Lilly, the American drug giant, had another record-breaking quarter. The weight-loss injection Zepbound saw sales soar 46% in the second quarter to $4.9 billion. The FactSet consensus was for $4.7 ...

Lizzy led STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Eli Lilly said it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, as it succeeds in two more late-stage trials. The drug delivered significant ...